Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
4 Results Found
AHA Comments on DEA Proposed Rule on Special Registrations for Telemedicine Prescribing
AHA comments regarding the Drug Enforcement Administration’s proposed rule for Special Registrations for Telemedicine and Limited State Telemedicine Registrations.
Telemedicine Prescribing of Controlled Substances
The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Jan. 15 released a proposed rule on special registration for prescribing of controlled substances and a final rule on telemedicine prescribing of buprenorphine.
DEA and HHS Extend Waivers Prescribing Controlled Substances through Telemedicine
The Drug Enforcement Administration (DEA) and Department of Health and Human Services (HHS) on Nov. 15 published a rule to extend waiver flexibilities for prescribing controlled substances via telemedicine.
AHA Requests Flexibility Extension on DEA Telemedicine Prescribing
AHA comments to the Drug Enforcement Administration regarding their efforts to support the safe prescribing of controlled substances via telehealth. Indeed, during the COVID-19 public health emergency